Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Children’s Mpox Shots Arriving
Children’s Mpox Shots Arriving as Congo Fights Mystery Disease
Mpox vaccines that young children can use will arrive from Japan next week, a crucial step in reducing the spread of the disease that has killed about 1,200 people in the Democratic Republic of Congo this year.
Child-safe mpox vaccine due to arrive in Democratic Republic of Congo
The Japanese-made vaccine should arrive in the country as early as next week, as the number of cases continues to surge.
Congo to get Japan's mpox vaccine for children from next week, Africa CDC says
Democratic Republic of Congo should start to receive three million doses of mpox vaccine from Japan next week that can be used on children, the Africa Centres for Disease Control and Prevention (Africa CDC) said on Thursday.
Congo to get Japan's mpox vaccine for children, Africa CDC says
The Democratic Republic of Congo should start to receive 3 million doses of mpox vaccine from Japan next week that can be used for children, the Africa Centers for Disease Control and Prevention (Africa CDC) said on Thursday.
New Scientist
6h
Mpox became a global health emergency for the second time in 2024
Surging mpox cases in East, West and Central Africa prompted the World Health Organization to once again make the infection a ...
HealthDay on MSN
2h
Who's Most Likely to Get the Mpox Shot in U.S.?
When an outbreak of mpox first hit the United States in 2022, a vaccine called Jynneos was available to help protect the most ...
FiercePharma
1d
Siga's smallpox antiviral Tpoxx misses the mark in another mpox study
It’s déjà vu for Siga Technologies and its smallpox antiviral Tpoxx. At an interim analysis of a second mpox trial, the drug ...
3d
Siga's mpox drug did not improve lesion resolution or pain, NIH study finds
Siga Technologies' antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among ...
Rutgers University
3d
Mpox Vaccination Rates Highest Among Cisgender Sexual Minority Men
As a second wave of the viral disease looms, Rutgers Health researchers call for more studies on long-term immunity.
pharmaphorum
1d
NIH abandons trial of SIGA's mpox drug
As a result of the preliminary STOMP data – which gave the chances of a positive outcome from the study at less than 1% – the ...
4d
on MSN
Morocco produces Africa’s first mpox tests as the continent tries to rely less on imports
After African countries struggled to get testing kits during the COVID-19 pandemic, officials vowed to make the continent ...
EurekAlert!
3d
NIH study finds tecovirimat was safe but did not improve mpox resolution or pain
The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild ...
cidrap.umn
2d
Trial stops enrollment after Tpoxx fails to speed clade 2 mpox healing or pain relief
STOMP is a randomized, controlled, double-blind trial to evaluate the safety and effectiveness of Tpoxx for treating mpox. In ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Japan
Democratic Republic of the Congo
Africa CDC
Tpoxx
Morocco
Feedback